{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:27:47Z","timestamp":1793399267278,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"}],"funder":[{"name":"Universit\u00e4tsklinikum RWTH Aachen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n                  <jats:p>F\u00fcr die oligoartikul\u00e4re Form der juvenilen idiopathischen Arthritis (JIA) wurden im Rahmen eines konsentierten Prozesses Protokolle entwickelt, welche die Klassifikation, \u00dcberwachung und Therapie betreffen (ProKind Rheuma). Durch die Autorengruppe wurden 23\u00a0Statements formuliert und diese im Rahmen eines Online-Survey zur Beteiligung unter den \u00e4rztlichen Mitgliedern der Gesellschaft f\u00fcr Kinder- und Jugendrheumatologie (GKJR) zirkuliert. An der Beantwortung des Surveys nahmen insgesamt\u00a080 der insgesamt 124 Kinder- und JugendrheumatologInnen teil; dies entspricht einem Anteil von knapp 65\u202f% der zu dem Zeitpunkt aktiven Kinder- und JugendrheumatologInnen. In einem abschlie\u00dfenden Online-Meeting wurden Anmerkungen aus der Umfrage in die Statements eingearbeitet und dann von der Autorengruppe konsentiert. F\u00fcr die neu auftretende oligoartikul\u00e4re JIA wurden 20\u00a0Statements und ein zusammenfassendes Konsensus-Therapieprotokoll entwickelt; diese sollen die Behandlung der persistierenden oligoartikul\u00e4ren JIA optimieren.<\/jats:p>","DOI":"10.1007\/s00393-025-01762-5","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:58:55Z","timestamp":1765540735000},"page":"45-53","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Juvenile idiopathische Arthritis\u00a0\u2013 persistierender oligoartikul\u00e4rer Subtyp","Juvenile idiopathic arthritis\u2014persistent oligoarticular subtype"],"prefix":"10.1007","volume":"85","author":[{"given":"Joachim","family":"Peitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Horneff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Raab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Winowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Hansmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Tenbrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Kommission Pro-Kind der Gesellschaft f\u00fcr Kinder- und Jugendrheumatologie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"1762_CR1","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1007\/s10067-005-1116-7","volume":"24","author":"R Brik","year":"2005","unstructured":"Brik\u00a0R, Gepstein\u00a0V, Berkovitz\u00a0D (2005) Low-dose methotrexate treatment for oligoarticular juvenile idiopathic arthritis nonresponsive to intra-articular corticosteroids. Clin Rheumatol 24:612\u2013614","journal-title":"Clin Rheumatol"},{"key":"1762_CR2","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1002\/art.34373","volume":"64","author":"A Consolaro","year":"2012","unstructured":"Consolaro\u00a0A, Bracciolini\u00a0G, Ruperto\u00a0N, Pistorio\u00a0A, Magni-Manzoni\u00a0S, Malattia\u00a0C, Pederzoli\u00a0S, Dav\u00ec\u00a0S, Martini\u00a0A, Ravelli\u00a0A (2012) Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: defining criteria based on the juvenile arthritis disease activity score. Arthritis Rheum 64:2366\u20132374","journal-title":"Arthritis Rheum"},{"key":"1762_CR3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12969-021-00520-6","volume":"19","author":"R Harhay","year":"2021","unstructured":"Harhay\u00a0R, Jeelani\u00a0W, Agbor\u00a0BTA, Hennon\u00a0T, Wrotniak\u00a0BH, Abdul-Aziz\u00a0R (2021) Response to treatment with intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligo articular juvenile idiopathic arthritis. Pediatr Rheumatol Online\u00a0J 19:36","journal-title":"Pediatr Rheumatol Online J"},{"key":"1762_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12969-018-0224-2","volume":"16","author":"CH Hinze","year":"2018","unstructured":"Hinze\u00a0CH, Holzinger\u00a0D, Lainka\u00a0E, Haas\u00a0JP, Speth\u00a0F, Kallinich\u00a0T, Rieber\u00a0N, Hufnagel\u00a0M, Jansson\u00a0AF, Hedrich\u00a0C, Winowski\u00a0H, Berger\u00a0T, Foeldvari\u00a0I, Ganser\u00a0G, Hospach\u00a0A, Huppertz\u00a0HI, M\u00f6nkem\u00f6ller\u00a0K, Neudorf\u00a0U, Wei\u00dfbarth-Riedel\u00a0E, Wittkowski\u00a0H, Horneff\u00a0G, Foell\u00a0D (2018) Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany. Pediatr Rheumatol Online\u00a0J 16:7","journal-title":"Pediatr Rheumatol Online J"},{"key":"1762_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12969-017-0206-9","volume":"15","author":"G Horneff","year":"2017","unstructured":"Horneff\u00a0G, Klein\u00a0A, Ganser\u00a0G, Sailer-H\u00f6ck\u00a0M, G\u00fcnther\u00a0A, Foeldvari\u00a0I, Weller-Heinemann\u00a0F (2017) Protocols on classification, monitoring and therapy in children\u2019s rheumatology (PRO-KIND): results of the working group Polyarticular juvenile idiopathic arthritis. Pediatr Rheumatol Online\u00a0J 15:78","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"1762_CR6","first-page":"133","volume":"38","author":"A Hospach","year":"2018","unstructured":"Hospach\u00a0A, Trauzeddel\u00a0R, Windschall\u00a0D et\u00a0al (2018) Enthesitis-assoziierte Arthritis. Protokolle zur Klassifikation, \u00dcberwachung und Therapie (ProKind). arthritis + Rheuma 38(2):133\u2013142","journal-title":"arthritis + Rheuma"},{"key":"1762_CR7","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1136\/annrheumdis-2019-216843","volume":"79","author":"A Klein","year":"2020","unstructured":"Klein\u00a0A, Minden\u00a0K, Hospach\u00a0A, Foeldvari\u00a0I, Weller-Heinemann\u00a0F, Trauzeddel\u00a0R, Huppertz\u00a0HI, Horneff\u00a0G (2020) Treat-to-target study for improved outcome in polyarticular juvenile idiopathic arthritis. Ann Rheum Dis 79:969\u2013974","journal-title":"Ann Rheum Dis"},{"key":"1762_CR8","doi-asserted-by":"publisher","first-page":"109143","DOI":"10.1016\/j.clim.2022.109143","volume":"245","author":"PT Oommen","year":"2022","unstructured":"Oommen\u00a0PT, Strauss\u00a0T, Baltruschat\u00a0K, Foeldvari\u00a0I, Deuter\u00a0C, Ganser\u00a0G, Haas\u00a0JP, Hinze\u00a0C, Holzinger\u00a0D, Hospach\u00a0A, Huppertz\u00a0HI, Illhardt\u00a0A, Jung\u00a0M, Kallinich\u00a0T, Klein\u00a0A, Minden\u00a0K, M\u00f6nkem\u00f6ller\u00a0K, Mrusek\u00a0S, Neudorf\u00a0U, D\u00fcckers\u00a0G, Niehues\u00a0T, Schneider\u00a0M, Schoof\u00a0P, Thon\u00a0A, Wachowsky\u00a0M, Wagner\u00a0N, Bloedt\u00a0S, Hofer\u00a0M, Tenbrock\u00a0K, Schuetz\u00a0C (2022) Update of evidence- and consensus-based guidelines for the treatment of juvenile idiopathic arthritis (JIA) by the German Society of Pediatric and Juvenile Rheumatic Diseases (GKJR): New perspectives on interdisciplinary care. Clin Immunol 245:109143","journal-title":"Clin Immunol"},{"key":"1762_CR9","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty\u00a0RE, Southwood\u00a0TR, Manners\u00a0P, Baum\u00a0J, Glass\u00a0DN, Goldenberg\u00a0J, He\u00a0X, Maldonado-Cocco\u00a0J, Orozco-Alcala\u00a0J, Prieur\u00a0AM, Suarez-Almazor\u00a0ME, Woo\u00a0P (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton. J\u00a0Rheumatol 31:390\u2013392","journal-title":"J Rheumatol"},{"key":"1762_CR10","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0140-6736(23)00921-2","volume":"402","author":"AV Ramanan","year":"2023","unstructured":"Ramanan\u00a0AV, Quartier\u00a0P, Okamoto\u00a0N, Foeldvari\u00a0I, Spindler\u00a0A, Fingerhutov\u00e1 \u0160, Ant\u00f3n\u00a0J, Wang\u00a0Z, Meszaros\u00a0G, Ara\u00fajo\u00a0J, Liao\u00a0R, Keller\u00a0S, Brunner\u00a0HI, Ruperto\u00a0N (2023) \u2018Baricitinib in juvenile idiopathic arthritis: an international, phase\u00a03, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial. Lancet 402:555\u2013570","journal-title":"Lancet"},{"key":"1762_CR11","first-page":"1283","volume":"27","author":"SE Ramsey","year":"2000","unstructured":"Ramsey\u00a0SE, Bolaria\u00a0RK, Cabral\u00a0DA, Malleson\u00a0PN, Petty\u00a0RE (2000) \u2018Comparison of criteria for the classification of childhood arthritis. J\u00a0Rheumatol 27:1283\u20131286","journal-title":"J Rheumatol"},{"key":"1762_CR12","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S0140-6736(17)30065-X","volume":"389","author":"A Ravelli","year":"2017","unstructured":"Ravelli\u00a0A, Dav\u00ec\u00a0S, Bracciolini\u00a0G, Pistorio\u00a0A, Consolaro\u00a0A, van Dijkhuizen\u00a0EHP, Lattanzi\u00a0B, Filocamo\u00a0G, Verazza\u00a0S, Gerloni\u00a0V, Gattinara\u00a0M, Pontikaki\u00a0I, Insalaco\u00a0A, De Benedetti\u00a0F, Civino\u00a0A, Presta\u00a0G, Breda\u00a0L, Marzetti\u00a0V, Pastore\u00a0S, Magni-Manzoni\u00a0S, Maggio\u00a0MC, Garofalo\u00a0F, Rigante\u00a0D, Gattorno\u00a0M, Malattia\u00a0C, Picco\u00a0P, Viola\u00a0S, Lanni\u00a0S, Ruperto\u00a0N, Martini\u00a0A (2017) Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a\u00a0multicentre, prospective, randomised, open-label trial. Lancet 389:909\u2013916","journal-title":"Lancet"},{"key":"1762_CR13","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1002\/art.22709","volume":"56","author":"RK Saurenmann","year":"2007","unstructured":"Saurenmann\u00a0RK, Rose\u00a0JB, Tyrrell\u00a0P, Feldman\u00a0BM, Laxer\u00a0RM, Schneider\u00a0R, Silverman\u00a0ED (2007) Epidemiology of juvenile idiopathic arthritis in a\u00a0multiethnic cohort: ethnicity as a\u00a0risk factor. Arthritis Rheum 56:1974\u20131984","journal-title":"Arthritis Rheum"},{"key":"1762_CR14","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1002\/art.41879","volume":"73","author":"C Trincianti","year":"2021","unstructured":"Trincianti\u00a0C, Van Dijkhuizen\u00a0EHP, Alongi\u00a0A, Mazzoni\u00a0M, Swart\u00a0JF, Nikishina\u00a0I, Lahdenne\u00a0P, Rutkowska-Sak\u00a0L, Avcin\u00a0T, Quartier\u00a0P, Panaviene\u00a0V, Uziel\u00a0Y, Pruunsild\u00a0C, Vargova\u00a0V, Vilaiyuk\u00a0S, Dolezalova\u00a0P, Ringold\u00a0S, Garrone\u00a0M, Ruperto\u00a0N, Ravelli\u00a0A, Consolaro\u00a0A (2021) Definition and Validation of the American College of Rheumatology 2021 Juvenile Arthritis Disease Activity Score Cutoffs for Disease Activity States in Juvenile Idiopathic Arthritis. Arthritis Rheumatol 73:1966\u20131975","journal-title":"Arthritis Rheumatol"},{"key":"1762_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13075-024-03303-y","volume":"26","author":"M Zajc Avramovi\u010d","year":"2024","unstructured":"Zajc Avramovi\u010d\u00a0M, Toplak\u00a0N, Markelj\u00a0G, Emer\u0161i\u010d\u00a0N, Av\u010din\u00a0T (2024) Long-term follow-up of 109 children with juvenile idiopathic oligoarthritis after first intra-articular corticosteroid injection. Arthritis Res Ther 26:69","journal-title":"Arthritis Res Ther"},{"key":"1762_CR16","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1093\/rheumatology\/keg358","volume":"42","author":"F Zulian","year":"2003","unstructured":"Zulian\u00a0F, Martini\u00a0G, Gobber\u00a0D, Agosto\u00a0C, Gigante\u00a0C, Zacchello\u00a0F (2003) Comparison of intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligoarticular juvenile idiopathic arthritis. Rheumatol (oxford) 42:1254\u20131259","journal-title":"Rheumatol (oxford)"},{"key":"1762_CR17","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1093\/rheumatology\/keh313","volume":"43","author":"F Zulian","year":"2004","unstructured":"Zulian\u00a0F, Martini\u00a0G, Gobber\u00a0D, Plebani\u00a0M, Zacchello\u00a0F, Manners\u00a0P (2004) Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a\u00a0double-blind trial. Rheumatol (oxford) 43:1288\u20131291","journal-title":"Rheumatol (oxford)"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-025-01762-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-025-01762-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-025-01762-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T09:14:24Z","timestamp":1770196464000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-025-01762-5"}},"subtitle":["Konsensusbasierte Handlungsempfehlungen im Rahmen der ProKind Rheuma Initiative","Consensus-based treatment recommendations as part of the ProKind Rheuma Initiative"],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1762"],"URL":"https:\/\/doi.org\/10.1007\/s00393-025-01762-5","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"2 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.\u00a0Peitz, G.\u00a0Horneff, A.\u00a0Raab, H.\u00a0Winowski, S.\u00a0Hansmann, K.\u00a0Tenbrock und f\u00fcrdie geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}